ino-5401
·Code: INO-5401, INO-9012
ino-5401: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | Phase 1/Phase 2 |
Clinical Trials (1)
An Open-Label, Multi-Center Trial of INO-5401 + INO-9012 in Combination With Atezolizumab in Subjects With Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma
Frequently asked questions
Who is developing ino-5401?
ino-5401 is being developed by INOVIO PHARMACEUTICALS, INC..
How many clinical trials involve ino-5401?
BioSniper tracks 1 clinical trial involving ino-5401.
Get deeper analysis on ino-5401
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis